J B Chemicals and Pharmaceuticals Share Price Today | Stock Price & J B Chemicals and Pharmaceuticals Share Screener
As of July 15, 2026, the live J B Chemicals and Pharmaceuticals share price (NSE: JBCHEPHARM) is ₹2,506.00 on NSE and ₹2,505.60 on BSE, up 0.74% from the previous close, with shares trading between ₹2,441.30 and ₹2,510.00 in today's trading session, and a 52-week range of ₹1,729.60–₹2,506.00. Track JBCHEPHARM market value to gauge the company's total market size. Use the J B Chemicals and Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today J B Chemicals and Pharmaceuticals opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹916 and net income of ₹101, with EBITDA of ₹186, an operating margin of 19.0% and a profit margin of 11.0%.
J B Chemicals and Pharmaceuticals Share Price Chart
Track the current stock price of J B Chemicals and Pharmaceuticals with an interactive chart. Analyse JBCHEPHARM share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete J B Chemicals and Pharmaceuticals stock quote in one place.
The quote of ₹2,506.00 sits between the 52-week low of ₹1,729.60 and the 52-week high of ₹2,506.00, and the latest session moved 0.74% from the previous close.
J B Chemicals and Pharmaceuticals Company Profile - Fundamental Screener
Screen J B Chemicals and Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for JBCHEPHARM shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, with Arun Duggal listed as chairperson or CEO, and it trades under ISIN INE572A01036.
Business Overview
J.B. Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company founded in 1976. It manufactures and markets a range of pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. The company specializes in gastroenterology, hypertension, and dermatology, with additional focus on nephrology, respiratory, virology, diabetes, and nicotine replacement therapy. Key brands...more
Company Details
Classification
Identifiers and Leadership
J B Chemicals and Pharmaceuticals Balance Sheet Screener
Screen JBCHEPHARM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹4,969, up from ₹4,274 in 2025.
Latest statistics put total assets at ₹4,969 and shareholder funds at ₹4,159.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 4,969 | 4,274 | 3,994 | 3,554 | 2,607 | 2,238 | 1,821 | 1,792 | 1,765 | 1,674 |
| Current Assets | 2,909 | 1,923 | 1,853 | 1,528 | 1,253 | 1,553 | 1,073 | 1,051 | 1,047 | 795 |
| Fixed Assets | 1,885 | 1,968 | 2,004 | 1,901 | 1,277 | 634 | 651 | 621 | 640 | 679 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 218 | 208 | 203 | 519 | 85 | 79 | 69 | 65 | 46 | 27 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 4,159 | 3,433 | 2,923 | 2,480 | 2,139 | 1,813 | 1,438 | 1,483 | 1,444 | 1,366 |
| Share Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 17 | 17 |
| Reserves & Surplus | 4,143 | 3,418 | 2,908 | 2,465 | 2,119 | 1,794 | 1,420 | 1,464 | 1,425 | 1,347 |
J B Chemicals and Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen J B Chemicals and Pharmaceuticals income statement and profit fundamentals. Analyze JBCHEPHARM quarterly results. J B Chemicals and Pharmaceuticals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹916 and net profit was ₹101, equal to earnings per unit of ₹6.35, at an operating margin of 19%.
In that period expenses were ₹730, interest cost ₹1 and tax ₹33. The next period listed, 2025-Dec, shows revenue of ₹1,083 and net profit of ₹198.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 916 | 1,083 | 1,100 | 1,109 | 964 | 972 | 1,011 | 1,010 | 878 | 852 | 889 | 902 | 767 | 796 | 811 |
| Expenses | 730 | 769 | 775 | 793 | 723 | 709 | 730 | 724 | 664 | 621 | 638 | 664 | 599 | 618 | 625 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 186 | 314 | 325 | 315 | 241 | 263 | 281 | 286 | 215 | 231 | 251 | 238 | 168 | 178 | 186 |
| Operating Profit % | 19.00% | 28.00% | 29.00% | 28.00% | 24.00% | 26.00% | 27.00% | 28.00% | 23.00% | 26.00% | 28.00% | 26.00% | 21.00% | 22.00% | 23.00% |
| Depreciation | 50 | 45 | 44 | 43 | 46 | 42 | 42 | 41 | 41 | 34 | 32 | 31 | 32 | 28 | 28 |
| Interest | 1 | 2 | 1 | 1 | 2 | 3 | 2 | 6 | 9 | 13 | 10 | 12 | 14 | 8 | 8 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 135 | 267 | 279 | 272 | 193 | 218 | 237 | 240 | 165 | 184 | 209 | 194 | 123 | 141 | 150 |
| Tax | 33 | 69 | 71 | 69 | 47 | 56 | 62 | 63 | 38 | 50 | 58 | 52 | 35 | 35 | 39 |
| Net Profit | 101 | 198 | 208 | 202 | 146 | 163 | 175 | 177 | 126 | 134 | 151 | 142 | 88 | 106 | 111 |
| EPS | 6.35 | 12.63 | 13.29 | 12.99 | 9.36 | 10.46 | 11.24 | 11.39 | 8.22 | 8.62 | 9.72 | 9.20 | 11.33 | 13.72 | 14.37 |
J B Chemicals and Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen JBCHEPHARM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹704, and net cash flow was an outflow of ₹5.
Over the same period, investing activities used ₹586 and financing activities used ₹123.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 704 | 903 | 801 | 626 | 170 | 315 | 276 | 194 | 123 | 201 |
| Investing Activities | -586 | -296 | -404 | -962 | 2 | -231 | 24 | -28 | -21 | -45 |
Financing and Net Cash | ||||||||||
| Financing Activities | -123 | -580 | -386 | 357 | -138 | -87 | -306 | -156 | -60 | -184 |
| Net Cash Flow | -5 | 27 | 11 | 20 | 34 | -3 | -6 | 11 | 43 | -28 |
J B Chemicals and Pharmaceuticals Shareholding Pattern Screener
See J B Chemicals and Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check J B Chemicals and Pharmaceuticals promoter holding and ownership changes for JBCHEPHARM on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 48.80%, foreign institutions 16.33%, domestic institutions 21.38% and the public 11.77%, spread across 74,043 shareholders.
The shareholder count was 74,043 in 2026-Mar, compared with 68,966 in 2026-Jan.
| Item | 2026-Mar | 2026-Jan | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 48.80% | 48.78% | 47.84% | 47.73% | 47.56% | 47.55% | 53.78% | 53.77% |
Institutional Investors | ||||||||
| FII Holding | 16.33% | 14.56% | 18.30% | 17.77% | 15.30% | 14.88% | 11.06% | 12.17% |
| DII Holding | 21.38% | 22.71% | 18.72% | 19.63% | 22.83% | 23.36% | 18.38% | 17.62% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 0.00% |
| Public Holding | 11.77% | 12.03% | 13.28% | 13.04% | 12.47% | 12.37% | 14.69% | 14.38% |
| Other Holding | 1.71% | 1.92% | 1.86% | 1.83% | 1.84% | 1.85% | 2.09% | 2.05% |
| Shareholder Count | 74,043 | 68,966 | 63,948 | 70,064 | 71,957 | 69,338 | 63,892 | 66,953 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by J B Chemicals and Pharmaceuticals. J B Chemicals and Pharmaceuticals dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹22.00 per unit for 2026-March, a yield of 0.88%, compared with ₹15.50 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹22.00, ₹15.50 and ₹12.25 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹22.00 | 0.88% |
| 2025-March | ₹15.50 | 0.75% |
| 2024-March | ₹12.25 | 0.75% |
| 2023-March | ₹17.75 | 1.08% |
| 2022-March | ₹16.50 | 1.67% |
| 2021-March | ₹16.50 | 2.10% |
| 2020-March | ₹11.00 | 1.75% |
| 2019-March | ₹5.00 | 1.96% |
| 2018-March | ₹2.00 | 1.10% |
| 2017-March | ₹1.00 | 0.64% |
J B Chemicals and Pharmaceuticals Stock Index Membership - Nifty & Sensex
See which indices include J B Chemicals and Pharmaceuticals stock. Check JBCHEPHARM index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 20 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX MSL400.
Complete Index List
J B Chemicals and Pharmaceuticals Market Events Screener - Corporate Actions
Get J B Chemicals and Pharmaceuticals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check J B Chemicals and Pharmaceuticals stock events that may affect JBCHEPHARM share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Merger - Demerger dated July 17, 2026, with a record date of July 17, 2026.
It is followed by Annual General Meeting dated June 17, 2026 and Dividend dated May 29, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-17 | 2026-07-17 | Merger - Demerger | 100:51 | 0.00% |
| 2026-06-17 | 2026-06-17 | Annual General Meeting | NA | 0.01% |
| 2026-05-29 | 2026-05-29 | Dividend | ₹ 9.30 /share | 2.44% |
| 2026-05-11 | 2026-05-11 | Quarterly Result Announcement | NA | 3.25% |
| 2026-04-28 | 2026-04-28 | Extraordinary General Meeting | NA | -1.68% |
| 2026-02-11 | 2026-02-11 | Dividend | ₹ 12.70 /share | 1.60% |
| 2026-01-16 | 2026-01-16 | Quarterly Result Announcement | NA | 4.16% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 6.12% |
| 2025-08-06 | 2025-08-06 | Annual General Meeting | NA | 4.95% |
| 2025-07-30 | 2025-07-30 | Quarterly Result Announcement | NA | 9.13% |
| 2025-07-30 | 2025-07-30 | Dividend | ₹ 7.00 /share | 14.10% |
| 2025-05-14 | 2025-05-14 | Quarterly Result Announcement | NA | -4.75% |
| 2025-02-07 | 2025-02-08 | Dividend | ₹ 8.50 /share | -2.35% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | -5.04% |
| 2024-11-06 | 2024-11-06 | Quarterly Result Announcement | NA | -2.31% |
J B Chemicals and Pharmaceuticals Competitors Screener - Peer Stocks Comparison
Screen JBCHEPHARM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 468,230 | 40.45 | 61,674 | 12.69% | 11,565 | 69.50 |
| Divis Laboratories | 193,075 | 74.28 | 10,560 | 8.73% | 2,520 | 73.34 |
| Torrent Pharmaceuticals | 169,825 | 78.68 | 13,886 | 20.34% | 2,138 | 80.61 |
| Zydus Life Science | 116,411 | 22.08 | 27,658 | 17.64% | 5,026 | 64.38 |
| Cipla | 116,168 | 30.10 | 29,045 | 2.24% | 3,870 | 55.25 |
| Lupin | 113,988 | 21.08 | 27,488 | 19.98% | 5,345 | 65.40 |
| Mankind Pharma | 105,029 | 53.92 | 14,278 | 12.03% | 1,750 | 59.45 |
| Dr Reddys Laboratories | 102,623 | 25.01 | 35,059 | 3.90% | 4,158 | 34.68 |
| Aurobindo Pharma | 89,195 | 25.75 | 33,385 | 3.21% | 3,376 | 54.09 |
| Laurus Labs | 83,910 | 94.65 | 6,868 | 22.01% | 890 | 65.68 |
J B Chemicals and Pharmaceuticals Company Announcements - News & Reports Screener
Screen JBCHEPHARM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated November 13, 2026.
The next most recent announcements are dated November 12, 2026 and November 12, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-11-13 | Intimation Of Effective Date Of Scheme Of Amalgamation Of J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders | - |
| 2026-11-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-11-12 | Record Date For The Purpose Of Determining The Shareholders Of The Company Who Shall Be Entitled To Receive Fully Paid-Up Equity Shares Of Torrent Pharma As Per The Share Exchange Ratio | - |
| 2026-11-12 | Receipt Of Certified Copy Of Order Passed By National Company Law Tribunal Ahmedabad Bench (NCLT) Regarding The Scheme Of Amalgamation Of J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders. | - |
| 2026-11-11 | Pronouncement Of Final Order By The HonBle National Company Law Tribunal Ahmedabad Bench Sanctioning The Scheme Of Amalgamation Of J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders | - |
| 2026-06-30 | Closure of Trading Window | - |
| 2026-06-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-06-17 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-06-17 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-06-15 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-06-12 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-27 | Letter To Shareholders - Integrated Annual Report 2025-26 | - |
| 2026-05-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-25 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-05-25 | Reg. 34 (1) Annual Report. | - |
| 2026-05-25 | Intimation Of Notice Of AGM To Be Held On June 17 2026 | - |
| 2026-05-22 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-21 | Intimation Of Record Date | - |
| 2026-05-20 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹2,506.00, within a 52-week range of ₹1,729.60 to ₹2,506.00. The P/E ratio is 56.28 and the P/B ratio is 9.60, with earnings per unit of ₹45.16. Market capitalisation stands at ₹40,236.01 Cr and the dividend yield is 0.88%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.